細胞生存アッセイの世界市場（～2026年）

• 英文タイトル：Global Cell Viability Assays Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11311 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は細胞生存アッセイのグローバル市場について調査・分析したレポートです。種類別（ヒト細胞、微生物細胞、動物細胞）市場規模、用途別（製薬・バイオ技術企業、学術研究機関、病院・診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別細胞生存アッセイの競争状況、市場シェア ・世界の細胞生存アッセイ市場：種類別市場規模 2015年-2020年（ヒト細胞、微生物細胞、動物細胞） ・世界の細胞生存アッセイ市場：種類別市場規模予測 2021年-2026年（ヒト細胞、微生物細胞、動物細胞） ・世界の細胞生存アッセイ市場：用途別市場規模 2015年-2020年（製薬・バイオ技術企業、学術研究機関、病院・診断研究所、その他） ・世界の細胞生存アッセイ市場：用途別市場規模予測 2021年-2026年（製薬・バイオ技術企業、学術研究機関、病院・診断研究所、その他） ・北米の細胞生存アッセイ市場分析：米国、カナダ ・ヨーロッパの細胞生存アッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの細胞生存アッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の細胞生存アッセイ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの細胞生存アッセイ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Merck、Bio-Rad、GE、Danaher、BD、PerkinElmer、Promega、Biotium、Abcam、Creative Bioarray、Biotek Instruments ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.

Market Analysis and Insights: Global Cell Viability Assays Market
The global Cell Viability Assays market size is projected to reach US$ 2584.3 million by 2026, from US$ 2457.8 million in 2020, at a CAGR of 4.8%% during 2021-2026.

Global Cell Viability Assays Scope and Market Size
Cell Viability Assays market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cell Viability Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
Abcam
Creative Bioarray
Biotek Instruments

Market segment by Type, the product can be split into
Human Cells
Microbial Cells
Animal Cells
Market segment by Application, split into
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospital and Diagnostic Laboratories
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell Viability Assays Revenue
1.4 Market by Type
1.4.1 Global Cell Viability Assays Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Cells
1.4.3 Microbial Cells
1.4.4 Animal Cells
1.5 Market by Application
1.5.1 Global Cell Viability Assays Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical and Biotechnology Companies
1.5.3 Academic and Research Institutes
1.5.4 Hospital and Diagnostic Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cell Viability Assays Market Perspective (2015-2026)
2.2 Global Cell Viability Assays Growth Trends by Regions
2.2.1 Cell Viability Assays Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cell Viability Assays Historic Market Share by Regions (2015-2020)
2.2.3 Cell Viability Assays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cell Viability Assays Market Growth Strategy
2.3.6 Primary Interviews with Key Cell Viability Assays Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cell Viability Assays Players by Market Size
3.1.1 Global Top Cell Viability Assays Players by Revenue (2015-2020)
3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2015-2020)
3.1.3 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell Viability Assays Market Concentration Ratio
3.2.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2019
3.3 Cell Viability Assays Key Players Head office and Area Served
3.4 Key Players Cell Viability Assays Product Solution and Service
3.5 Date of Enter into Cell Viability Assays Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cell Viability Assays Historic Market Size by Type (2015-2020)
4.2 Global Cell Viability Assays Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cell Viability Assays Market Size by Application (2015-2020)
5.2 Global Cell Viability Assays Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cell Viability Assays Market Size (2015-2020)
6.2 Cell Viability Assays Key Players in North America (2019-2020)
6.3 North America Cell Viability Assays Market Size by Type (2015-2020)
6.4 North America Cell Viability Assays Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cell Viability Assays Market Size (2015-2020)
7.2 Cell Viability Assays Key Players in Europe (2019-2020)
7.3 Europe Cell Viability Assays Market Size by Type (2015-2020)
7.4 Europe Cell Viability Assays Market Size by Application (2015-2020)

8 China
8.1 China Cell Viability Assays Market Size (2015-2020)
8.2 Cell Viability Assays Key Players in China (2019-2020)
8.3 China Cell Viability Assays Market Size by Type (2015-2020)
8.4 China Cell Viability Assays Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cell Viability Assays Market Size (2015-2020)
9.2 Cell Viability Assays Key Players in Japan (2019-2020)
9.3 Japan Cell Viability Assays Market Size by Type (2015-2020)
9.4 Japan Cell Viability Assays Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cell Viability Assays Market Size (2015-2020)
10.2 Cell Viability Assays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell Viability Assays Market Size by Type (2015-2020)
10.4 Southeast Asia Cell Viability Assays Market Size by Application (2015-2020)

11 India
11.1 India Cell Viability Assays Market Size (2015-2020)
11.2 Cell Viability Assays Key Players in India (2019-2020)
11.3 India Cell Viability Assays Market Size by Type (2015-2020)
11.4 India Cell Viability Assays Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cell Viability Assays Market Size (2015-2020)
12.2 Cell Viability Assays Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell Viability Assays Market Size by Type (2015-2020)
12.4 Central & South America Cell Viability Assays Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
13.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Cell Viability Assays Introduction
13.2.4 Merck Revenue in Cell Viability Assays Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Bio-Rad
13.3.1 Bio-Rad Company Details
13.3.2 Bio-Rad Business Overview
13.3.3 Bio-Rad Cell Viability Assays Introduction
13.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2015-2020)
13.3.5 Bio-Rad Recent Development
13.4 GE
13.4.1 GE Company Details
13.4.2 GE Business Overview
13.4.3 GE Cell Viability Assays Introduction
13.4.4 GE Revenue in Cell Viability Assays Business (2015-2020)
13.4.5 GE Recent Development
13.5 Danaher
13.5.1 Danaher Company Details
13.5.2 Danaher Business Overview
13.5.3 Danaher Cell Viability Assays Introduction
13.5.4 Danaher Revenue in Cell Viability Assays Business (2015-2020)
13.5.5 Danaher Recent Development
13.6 BD
13.6.1 BD Company Details
13.6.2 BD Business Overview
13.6.3 BD Cell Viability Assays Introduction
13.6.4 BD Revenue in Cell Viability Assays Business (2015-2020)
13.6.5 BD Recent Development
13.7 PerkinElmer
13.7.1 PerkinElmer Company Details
13.7.2 PerkinElmer Business Overview
13.7.3 PerkinElmer Cell Viability Assays Introduction
13.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2015-2020)
13.7.5 PerkinElmer Recent Development
13.8 Promega
13.8.1 Promega Company Details
13.8.2 Promega Business Overview
13.8.3 Promega Cell Viability Assays Introduction
13.8.4 Promega Revenue in Cell Viability Assays Business (2015-2020)
13.8.5 Promega Recent Development
13.9 Biotium
13.9.1 Biotium Company Details
13.9.2 Biotium Business Overview
13.9.3 Biotium Cell Viability Assays Introduction
13.9.4 Biotium Revenue in Cell Viability Assays Business (2015-2020)
13.9.5 Biotium Recent Development
13.10 Abcam
13.10.1 Abcam Company Details
13.10.2 Abcam Business Overview
13.10.3 Abcam Cell Viability Assays Introduction
13.10.4 Abcam Revenue in Cell Viability Assays Business (2015-2020)
13.10.5 Abcam Recent Development
13.11 Creative Bioarray
10.11.1 Creative Bioarray Company Details
10.11.2 Creative Bioarray Business Overview
10.11.3 Creative Bioarray Cell Viability Assays Introduction
10.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2015-2020)
10.11.5 Creative Bioarray Recent Development
13.12 Biotek Instruments
10.12.1 Biotek Instruments Company Details
10.12.2 Biotek Instruments Business Overview
10.12.3 Biotek Instruments Cell Viability Assays Introduction
10.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2015-2020)
10.12.5 Biotek Instruments Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Cell Viability Assays Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Viability Assays Revenue
Table 3. Ranking of Global Top Cell Viability Assays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Human Cells
Table 6. Key Players of Microbial Cells
Table 7. Key Players of Animal Cells
Table 8. Global Cell Viability Assays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cell Viability Assays Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cell Viability Assays Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cell Viability Assays Market Share by Regions (2015-2020)
Table 12. Global Cell Viability Assays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cell Viability Assays Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cell Viability Assays Market Growth Strategy
Table 18. Main Points Interviewed from Key Cell Viability Assays Players
Table 19. Global Cell Viability Assays Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cell Viability Assays Market Share by Players (2015-2020)
Table 21. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Viability Assays as of 2019)
Table 22. Global Cell Viability Assays by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cell Viability Assays Product Solution and Service
Table 25. Date of Enter into Cell Viability Assays Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cell Viability Assays Market Size Share by Type (2015-2020)
Table 29. Global Cell Viability Assays Revenue Market Share by Type (2021-2026)
Table 30. Global Cell Viability Assays Market Size Share by Application (2015-2020)
Table 31. Global Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cell Viability Assays Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cell Viability Assays Market Share (2019-2020)
Table 35. North America Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cell Viability Assays Market Share by Type (2015-2020)
Table 37. North America Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cell Viability Assays Market Share by Application (2015-2020)
Table 39. Europe Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cell Viability Assays Market Share (2019-2020)
Table 41. Europe Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cell Viability Assays Market Share by Type (2015-2020)
Table 43. Europe Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cell Viability Assays Market Share by Application (2015-2020)
Table 45. China Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cell Viability Assays Market Share (2019-2020)
Table 47. China Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 48. China Cell Viability Assays Market Share by Type (2015-2020)
Table 49. China Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 50. China Cell Viability Assays Market Share by Application (2015-2020)
Table 51. Japan Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cell Viability Assays Market Share (2019-2020)
Table 53. Japan Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cell Viability Assays Market Share by Type (2015-2020)
Table 55. Japan Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cell Viability Assays Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cell Viability Assays Market Share (2019-2020)
Table 59. Southeast Asia Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cell Viability Assays Market Share by Type (2015-2020)
Table 61. Southeast Asia Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cell Viability Assays Market Share by Application (2015-2020)
Table 63. India Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cell Viability Assays Market Share (2019-2020)
Table 65. India Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 66. India Cell Viability Assays Market Share by Type (2015-2020)
Table 67. India Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 68. India Cell Viability Assays Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cell Viability Assays Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cell Viability Assays Market Share (2019-2020)
Table 71. Central & South America Cell Viability Assays Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cell Viability Assays Market Share by Type (2015-2020)
Table 73. Central & South America Cell Viability Assays Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cell Viability Assays Market Share by Application (2015-2020)
Table 75. Thermo Fisher Scientific Company Details
Table 76. Thermo Fisher Scientific Business Overview
Table 77. Thermo Fisher Scientific Product
Table 78. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 79. Thermo Fisher Scientific Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Bio-Rad Company Details
Table 86. Bio-Rad Business Overview
Table 87. Bio-Rad Product
Table 88. Bio-Rad Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 89. Bio-Rad Recent Development
Table 90. GE Company Details
Table 91. GE Business Overview
Table 92. GE Product
Table 93. GE Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 94. GE Recent Development
Table 95. Danaher Company Details
Table 96. Danaher Business Overview
Table 97. Danaher Product
Table 98. Danaher Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 99. Danaher Recent Development
Table 100. BD Company Details
Table 101. BD Business Overview
Table 102. BD Product
Table 103. BD Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 104. BD Recent Development
Table 105. PerkinElmer Company Details
Table 106. PerkinElmer Business Overview
Table 107. PerkinElmer Product
Table 108. PerkinElmer Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 109. PerkinElmer Recent Development
Table 110. Promega Business Overview
Table 111. Promega Product
Table 112. Promega Company Details
Table 113. Promega Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 114. Promega Recent Development
Table 115. Biotium Company Details
Table 116. Biotium Business Overview
Table 117. Biotium Product
Table 118. Biotium Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 119. Biotium Recent Development
Table 120. Abcam Company Details
Table 121. Abcam Business Overview
Table 122. Abcam Product
Table 123. Abcam Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 124. Abcam Recent Development
Table 125. Creative Bioarray Company Details
Table 126. Creative Bioarray Business Overview
Table 127. Creative Bioarray Product
Table 128. Creative Bioarray Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 129. Creative Bioarray Recent Development
Table 130. Biotek Instruments Company Details
Table 131. Biotek Instruments Business Overview
Table 132. Biotek Instruments Product
Table 133. Biotek Instruments Revenue in Cell Viability Assays Business (2015-2020) (Million US$)
Table 134. Biotek Instruments Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Viability Assays Market Share by Type: 2020 VS 2026
Figure 2. Human Cells Features
Figure 3. Microbial Cells Features
Figure 4. Animal Cells Features
Figure 5. Global Cell Viability Assays Market Share by Application: 2020 VS 2026
Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Hospital and Diagnostic Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Viability Assays Report Years Considered
Figure 11. Global Cell Viability Assays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell Viability Assays Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell Viability Assays Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell Viability Assays Market Share by Players in 2019
Figure 16. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Viability Assays as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2019
Figure 18. North America Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell Viability Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

---